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Abstract
Pathology and radiology form the core of cancer
diagnosis, yet the workflows of both specialties
remain ad hoc and occur in separate “silos,” with no
direct linkage between their case accessioning and/or
reporting systems, even when both departments
belong to the same host institution. Because both
radiologists’ and pathologists’ data are essential to
making correct diagnoses and appropriate patient
management and treatment decisions, this isolation
of radiology and pathology workflows can be
detrimental to the quality and outcomes of patient
care. These detrimental effects underscore the need
for pathology and radiology workflow integration and
for systems that facilitate the synthesis of all data
produced by both specialties. With the enormous
technological advances currently occurring in both
fields, the opportunity has emerged to develop an
integrated diagnostic reporting system that supports
both specialties and, therefore, improves the overall
quality of patient care.
Keywords: Pathology, Radiology, Quality Improve-
ment, Health Information Technology, Standards,
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Background
Pathology and radiology form the core of cancer diagnosis.
Pathology characterizes the specific histologic and molecu-
lar features of tissues, while radiology localizes suspicious
lesions and informs clinical-stage and potential comorbid-
ity determinations. Under the current paradigm of diag-
nostic medicine, pathologists and radiologists function as
members of distinct disciplines, with no direct linkage
between their workflows or reporting systems. Even when
both departments belong to the same institution, their
respective reports on the same patient are only loosely
associated with one another by identifiers such as patient’s
name and medical record number. Despite this complete
bifurcation of reporting, the synthesis of both specialties’
data must establish diagnosis, determine prognosis, drive
patient management and serve as the primary means for
assessing response to treatment. Unfortunately, current
practice of reviewing pathologists’ and radiologists’ reports
is limited to hospital tumor boards that do not typically
review patients with negative pathological findings, and all
too often the responsibility for correlation falls on the clin-
ician ordering the study. Consequently, a radiology and
pathology diagnostic reporting system that integrates text,
sentinel images and molecular diagnostic data to an
integrated, coherent interpretation would better inform
management decisions.
Discussion
Documented disease-specific needs for radiology-
pathology integration in diagnostic medicine
Several studies have identified needs for the integration of
mammography and pathology reporting in the setting of
specific breast cancer diagnosis, where integration and
correlation between the two specialties was shown to
detect misdiagnosis and to prompt repeat biopsy in
instances of unexplained discrepancy between imaging
and pathologic findings [1-3]. Studies have also shown
that cooperation between pathologists and radiologists is
critical in some situations, for example, when sentinel
lymph nodes must be localized and when targeted lesions
and their resection margins must be localized and mapped
to determine the adequacy of the resection. This kind of
cooperation can both prevent the need for re-excision and
improve the reporting of survival-related prognostic para-
meters [4,5].
Recently, the benefits of pathology-radiology integration
have become apparent in other clinical settings. For exam-
ple, the new classification of lung adenocarcinoma by the
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the American Thoracic Society, and the European Respira-
tory Society acknowledges that an integrated, multidisci-
plinary approach to lung adenocarcinoma is required for
optimal patient care [6]. Factors that drove this conclusion
include specific molecular signatures in adenocarcinoma
that have led to specific, targeted therapies [7]. In addition,
lesion characterizations by high-resolution helical com-
puted tomography have introduced a new classification of
peripheral lung lesions, such as ground-glass and part-
solid nodules, that correlate with histologic features and
inform prognosis and therapy.
Similar diagnostic benefits from pathology-radiology
integration have been observed with regard to interstitial
lung disease. Historically, the diagnosis of interstitial lung
disease has been the domain of the pulmonologist, who is
required to independently correlate the histopathologic
report and radiographic findings to be able to identify
prognostically distinct subsets [8,9]. Recently, however, the
American Thoracic Society and the European Respiratory
Society have issued international consensus statements
that call for an integrated, dynamic interaction among
clinician, imager and pathologist to better inform the spe-
cific biological behavior and prognosis of subsets of inter-
stitial lung disease [10-12]. Three reasons motivated this
call for change:
▪ different patterns of interstitial lung disease can
coexist in different sites, so tissue sampling error
may be misleading in cases of such heterogeneity;
▪ an integrated report that includes both the histolo-
gic pattern of disease and the clinical and imaging
features can provide more accurate diagnostic and
prognostic information; and
▪ some cases of interstitial lung disease are histo-
pathologically indeterminate even for the most
experienced and specialized lung pathologists [13].
Moreover, studies of interstitial lung disease have
shown that such multidisciplinary interactions increase
interobserver agreement [14,15].
As with breast cancer and lung disease, the domains of
bone and soft-tissue disease diagnoses, including vascular
tumors and malformations, require pathology-radiology
integration. The anatomic location and radiographic fea-
tures of a bone or soft-tissue tumor, together with the his-
tologic morphology, determine the type and nature of a
specific tumor. Without integration of the diagnostic find-
ings, both the individual radiology and individual pathol-
ogy reports remain incomplete in the clinical setting
[16,17]. Finally, pathology-radiology integration may
improve the classification and diagnosis of vascular tumors
and malformations [18].
The general benefits of pathology-radiology integration
Beyond the documented need for improved manage-
ment of specific diseases, many potential benefits would
derive from pathology-radiology integration and, there-
fore, argue for its universal adoption. These include:
▪ Report standardization. Multidisciplinary colla-
borations foster the use of controlled terminologies
and standardized reporting structures, making eva-
luation across multiple patient cohorts possible.
▪ Clinical efficiency. Diagnostic radiology-pathology
integration would yield reporting that is accessible via
a single portal, which could free more time for inter-
pretation and decision making.
▪ Registry development. The aggregation of diag-
nostic imaging and pathology data into a single
resource would facilitate the development of rich data-
bases for disease registries, which would enable or
improve:
- quality assurance,
- identification of potential research cohorts,
- research data mining, and
- efficient access by tumor registries.
▪ Tumor board presentation. The integrated report
may lessen preparation time for multidisciplinary
tumor board conferences and would be a valuable edu-
cational resource for medical students and residents.
▪ Research and innovations. Recent advances in
both pathology and radiology, are encouraging more
cooperation between the two disciplines in situations
in which tumors can be identified with certainty at an
earlier stage than in the past and then characterized at
the molecular level. Rapid access to comprehensive
pathology and radiology findings will be necessary to
enable novel translational research activities, including,
for example, the use of a multidisciplinary Sequencing
Tumor Board as a means to assess the molecular find-
ings of specific patients and make recommendations
for their treatment [19].
▪ Improved patient care. Diagnostic radiology-
pathology integration would improve patient care. In
addition to the benefits noted above, greater coordina-
tion would encourage the use of less invasive techni-
ques, such as needle biopsies, while monitoring each
event to assure that adequate material is available for
additional studies, including molecular diagnostics.
Consequently, between the imaging and pathology
worlds, a movement is growing to develop systematic pro-
cesses that can exploit both the integration of diagnostic
information and the flow of small tissue samples obtained
from image-guided biopsy from radiology to pathology.
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This multidisciplinary effort has led to a number of
recommendations for pathologic and molecular diagnosis,
as well as radiologic practice.
The limitations of current workflows and the challenge of
the installed base
Many issues must be resolved before an integrated pathol-
ogy-radiology workflow can be adopted. The two disci-
plines rely on numerous legacy information systems.
Within pathology departments, for example, anatomical
pathology and clinical pathology frequently use different
information systems to track specimens and produce
reports. Anatomic pathology may also use a third system
to view and store pathology images. Similarly, radiologists
use a picture archiving and communication system to dis-
seminate and archive images and a radiology information
system to archive text reports. In response to the unique
needs of mammography screening and to ensure compli-
ance with the Mammography Quality Standards Act, radi-
ologists often also use a dedicated mammography
information system.
Moreover, for most intra-institutional communications
between radiology and pathology to occur, the radiology
and pathology systems must communicate not only with
one another, but also with other systems, including the
hospital information system, the laboratory information
system and electronic medical records. This extent of inte-
gration frequently requires expensive custom interfaces.
Aside from the cost of development, where an exchange
has been developed, implementation is typically incom-
plete. For example, current implementations fail to sup-
port the advanced Health Level 7 features required to
support anatomical pathology test-ordering and reporting
functions. In addition, the lack of integration between
commercially available information systems prevents a
unified view of a patient’s records, resulting in the need to
query multiple radiology and pathology systems. This
situation becomes even more complicated in settings
where the pathologist and radiologist do not share a com-
mon information technology infrastructure (for example,
interface with a common hospital Electronic Health
Record (EHR)). Many of these issues can be resolved
through the adoption of appropriate standards by system
vendors and end users.
Advances in standards and technology that enable
integration
Although the installed base has significant shortcomings,
some emerging standards and evolving pathology and
imaging technologies nonetheless present opportunities
to integrate radiology and pathology information.
Emerging standards in pathology and radiology
The following emerging standards have significant poten-
tial to resolve some of the current workflow challenges:
▪ The College of American Pathologists’ Electronic
Cancer Checklists (CAP eCC) are used to report
malignant findings in a structured format [20]. The
goal of the CAP eCC is to codify pertinent diagnos-
tic findings while meeting the requirements of the
American Joint Committee on Cancer staging.
▪ Until recently, the field of digital pathology had
been hindered by the lack of standards for storing
and transferring images. However, this issue was
addressed when the Digital Imaging and Communi-
cations in Medicine supplement for digital pathology
(Supplement 145)i was released in July 2010 [21].
▪ Many radiology groups are voluntarily implement-
ing the Radiological Society of North America’s
structured reporting templates [22]. Although the
structured reports must be customized to the needs
of the particular referring physician (for example,
emergency medicine reporting differs substantially
from medical oncology reporting), structured tem-
plates were found to improve patient care by
increasing clarity and thoroughness in the communi-
cation of imaging findings [23].
▪ RadLex is an evolving controlled terminology for
radiology reporting, teaching and research. Originally
designed to standardize terminologies only in chest
imaging, it now covers several facets of radiology,
with the following goals:
- to reduce interpretation variability,
- to map synonyms that refer to the same
concepts,
- to provide a terminology comprehensible for
both humans and computers,
- to facilitate data mining and querying of reports,
- to automate image annotation and computer-
aided diagnosis, and
- to enable teaching files and decision support
[24,25].
Technological advances in pathology
Two sets of emerging technologies in the field of pathol-
ogy could, especially when combined, lead to much more
efficient and thorough diagnoses and prognoses. First,
molecular diagnostic techniques have led to the incor-
poration of prognostic and predictive molecular biomar-
kers for the benefit of patient management. Second,
digital imaging with supervised, quantitative image analy-
sis will improve the informational content of integrated
reports and link users directly to digital images of the
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pathology slides. Quantitative image analysis will also
permit more reproducible evaluation of the morphologic
findings, specifically, expression of markers by immuno-
histochemistry. The benefits of combining these sources
of information into the pathology section of an integrated
pathology-radiology report include enhancement of the
pathology report itself and improved facilitation of con-
ference preparation and medical education; it would also
reduce the chance that these findings might be over-
looked, a risk that is increased if they are reported as
separate ancillary studies.
Technological advances in radiological imaging
As with pathology, radiology has two emerging technolo-
gies that invite integration. Now possible is the incorpora-
tion of the functional and physiologic information from
magnetic resonance and positron emission tomography
(PET) into radiology reports. PET scans, for example,
decrease the rate of biopsies in masses that are not deemed
active by imaging characteristics. Secondly, semi-auto-
mated quantitative image analysis is also now available and
amenable to integration into the radiology report. Evidence
is accumulating that computerized image analysis improves
radiologists’ diagnostic performance in terms of both the
detection and the characterization of diseases. Moreover,
this advanced image analysis has been shown to improve
diagnostic performance across a spectrum of diseases by
reducing reader variability and providing reproducible
quantification of features, such as tumor volume, consis-
tency and perfusion, yielding reliability not possible with
visual inspection alone [26-28]. These data are more valu-
able as complements to histology when contextualized by a
fully integrated report. In addition, when integrated, both
technologies have potential to improve the assessment of
treatment response and tracking of disease evolution.
Summary
The path forward: critical components of radiology-
pathology integration
The formal process of correlating radiology and pathology,
including the timely resolution of discordance, must be
supported. To this end, pathology-radiology integration
workflows must ensure the flow of communications and
specimens and link structured diagnostic results from
pathologists with those of radiologists. These processes
can be either asynchronous (that is, intermittent e-mail-
like exchanges) or synchronous (that is, conferences). The
workflow in Figure 1 proposes an idealized model that
maximizes pathology-radiology integration and identifies
Figure 1 Proposed idealized workflow model of radiology-pathology integration. Workflows are not designed around any specific disease;
they remain flexible to meet new clinical demands. This figure is from the US Health and Human Services Report titled “The importance of radiology
and pathology communication in the diagnosis and staging of cancer: mammography as a case study” (manuscript reference 3) and is thus not
copyrighted.
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key roles, including the referring clinician, the radiologist,
the pathologist and other users of radiology-pathology
information, such as cancer registries.
To enable the extent of the integrated diagnostic consul-
tation modeled in Figure 1, the following challenges must
be addressed:
• Structured reporting that includes the use of con-
trolled vocabularies is required to enable consistent
information content within both domains and better
automate concept extraction and database population.
• The specialties will require national practice guide-
lines to aid identification of possible discordant
pathology-radiology results. In addition to document-
ing and correlating positive pathology-radiology find-
ings, these guidelines should address the reporting of
benign or negative pathology results that become
especially problematic if benign pathology results are
discordant with radiology findings and which may,
therefore, cause an incorrect patient diagnosis.
• Vendors will have to act on these emerging oppor-
tunities by developing comprehensive management
systems that consider clinical workflow and support
the integration of textual, image and quantitative data
generated by both disciplines. Doing so will provide a
coherent and meaningful consultation resource and
data repository.
• The specialties must document the benefits of inte-
grated consultation on the bases of clinician feedback
and measurable changes in the efficiency and accu-
racy of diagnosis, treatment timing and, ultimately,
patient outcomes.
• The specialties must achieve interoperability in
situations where radiology and pathology are housed
in different institutions.
Despite technical challenges that limit integration
within current workflow models, the opportunity for
pathology-radiology integration to improve patient care
is great, and more importantly, the tools to achieve this
end exist. Institutions, such as Kansas University Medi-
cal Center and the University of California, Los Angeles,
have already begun implementing different models of
integration [3,29,30]. Other opportunities for achieving
integration involve developing models of pathology and
radiology collaboration that foster joint training and are
supported by innovative payment models. Member orga-
nizations can play an important role in fostering educa-
tional exchanges between the disciplines. Recently, for
example, the American College of Radiology launched
the American Institute for Radiologic Pathology. The
institute offers a Radiologic-Pathologic Correlation
course to radiology residents to provide them with an
opportunity to learn the pathologic counterpart to their
findings and emphasizes the correlation of pathology
and the medical images [31]. Implementing similar pro-
grams for both specialties during medical training and
as continuing-education opportunities would likely fos-
ter radiology-pathology integration on a wider scale.
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Endnotes
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